课题基金 / 基金详情

Spatiotemporal spread of inflammation caused by HMGB1 nuclear DNA-binding protein

Spatiotemporal spread of inflammation caused by HMGB1 nuclear DNA-binding protein
HMGB1 核 DNA 结合蛋白引起的炎症时空扩散
批准号:
23790447
负责人:
OYAMA Yoko
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012

项目摘要

项目成果

OYAMA Yoko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
High-mobility group box-1 protein (HMGB1) was originally described as a nuclear DNA-binding protein that facilitates gene transcription by stabilizing nucleosome formation. HMGB1 can also be released or secrete extracellularly from cells as a result of cellular necrosis or activated macrophages/monocytes in response to inflammatory stimuli respectively, and acts as a pro-inflammatory cytokine or alarm signal for tissue damage. We have revealed that HMGB1 can trigger a potent inflammatory response and accelerates granulomatous inflammation leading to severe tissue injury. In this study, we tried to disclose further mechanism of HMGB1- associated granulomatous inflammation. From a point of view that controlling HMGB1 is essential for treatment of granulomatous nephritis, we studied experiments using a granulomatous nephritis animal model to investigate follows;1. The relationship between degrees of the nephritis and HMGB1 receptors expression2. The effect of anti-HMGB1 antibody3. TM association of the nephritis4. Reactive oxygen species association of the nephritisWe have found that receptors of HMGB1 and TM could be a target for inhibiting granulomatous nephritis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Can Kampo Medicines treat chronic kidney disease? : Challenge to elucidate the inflammation control mechanism of traditional herbal medicine
  • 批准号:
    17K09310
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2017
  • 负责人:
    OYAMA Yoko
  • 依托单位:
国内基金
海外基金
糖尿病驱动AGEs积聚进而激活RAGE/DIAPH1/RhoA信号通路促进子宫内膜癌转移的机制研究
  • 批准号:
    JCZRLH202600969
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
靶向铁死亡/RAGE/CD44的中药纳米载药体系Ce-大黄酸-透明质酸对视网膜地图样萎缩的修复作用及机制研究
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
PRKCA通过HMGB1-RAGE信号轴调控星形胶质细胞活化在糖尿病周围神经病变性疼痛中的作用与机制研究
  • 批准号:
    2026JJ81777
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    邓淑文
  • 依托单位: